APA (7th ed.) Citation

Ganesapandian, M., Ramasamy, K., Adithan, S., & Narayan, S. (2019). Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on dose-adjusted plasma levels of carbamazepine in epileptic patients in South Indian population. Indian journal of pharmacology, 51(6), 384-388. https://doi.org/10.4103/ijp.IJP_122_19

Chicago Style (17th ed.) Citation

Ganesapandian, Mahalakshmi, Kesavan Ramasamy, Surendiran Adithan, and Sunil Narayan. "Influence of Cytochrome P450 3A5 (CYP3A5) Genetic Polymorphism on Dose-adjusted Plasma Levels of Carbamazepine in Epileptic Patients in South Indian Population." Indian Journal of Pharmacology 51, no. 6 (2019): 384-388. https://doi.org/10.4103/ijp.IJP_122_19.

MLA (9th ed.) Citation

Ganesapandian, Mahalakshmi, et al. "Influence of Cytochrome P450 3A5 (CYP3A5) Genetic Polymorphism on Dose-adjusted Plasma Levels of Carbamazepine in Epileptic Patients in South Indian Population." Indian Journal of Pharmacology, vol. 51, no. 6, 2019, pp. 384-388, https://doi.org/10.4103/ijp.IJP_122_19.